BioCryst Pharmaceuticals,Inc. (BCRX)

[apollo1452]

Read the 8/31/20 BCRX Galidesivir PR: "Conducting a Phase 2 Clinical Trial (NOT the Brazilian trial, IN ADDITION TO...) of Galidesivir in non-hospitalized COVID-19 patients at high risk for developing severe disease and complications of COVID-19."
https://ir.biocryst.com/node/21596/pdf

The PR does not say "will conduct". It specifically states "conducting a Phase 2 clinical trial of Galidesivir in non-hospitalized COVID-19 patients" as in another Galidesivir trial is already happening in the USA as part of Operation Warp Speed...

That statement fits perfectly with the ACTIV-2 COVID-19 therapeutic clinical trials sponsored by NIAID, the same agency that just gave BCRX another $47,000,000 for Galidesivir development...
https://www.newswise.com/coronavirus/actg-announces-launch-of-novel-clinical-trial-testing-multiple-therapeutics-to-treat-covid-19/?article_id=735820

BCRX potentially now has 3 "shots on goal" with antiviral Galidesivir for COVID-19:
1) Non human primate trials & Emergency Use Authorization thru FDA Animal Rule
2) Brazilian human clinical trial
3) NIAID sponsored ACTIV-2 phase 2 COVID-19 trial that is part of NIH Operation Warp Speed initiative.

We should definitely get some more Galidesivir news late September/early October.